Leslie Toth

Title: The Innovative Contributions of Leslie Toth

Introduction

Leslie Toth is a notable inventor based in Woodbridge, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors in the body. Her work has implications for immunosuppression, anti-inflammatory treatments, and enhancing vascular integrity.

Latest Patents

Leslie Toth holds a patent for her invention titled "(3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists." This patent encompasses compounds of Formula I, along with their pharmaceutically acceptable salts. The compounds are recognized as S1P/Edg1 receptor agonists, which exhibit immunosuppressive, anti-inflammatory, and hemostatic activities. These effects are achieved by modulating leukocyte trafficking, sequestering lymphocytes in secondary lymphoid tissues, and enhancing vascular integrity. The invention also includes pharmaceutical compositions containing these compounds and methods for treatment or prevention.

Career Highlights

Leslie Toth is currently employed at Merck & Company, Inc., where she continues to innovate and contribute to the pharmaceutical industry. Her work is characterized by a commitment to advancing medical science and improving patient outcomes through her inventions.

Collaborations

Leslie has collaborated with esteemed colleagues such as Vincent Colandrea and George A Doherty. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Leslie Toth's contributions to the field of pharmaceuticals through her innovative patents and collaborations highlight her role as a significant inventor. Her work not only advances scientific knowledge but also has the potential to improve healthcare outcomes for many individuals.